Primary vs. revision total elbow arthroplasty: an updated analysis of short-term complications and associated factors.

Background: Total elbow arthroplasty (TEA) is an increasingly utilized intervention for a range of pathologies. While the current literature landscape has emphasized reimbursement and long-term outcomes, for example, contemporary comparative data on short-term adverse events between primary and revision TEA remain limited. Therefore, this study updates and expands upon such short-term findings using a large database. Methods: In this retrospective cohort study, patients undergoing primary or revision TEA were identified in the American College of Surgeons National Surgical Quality Improvement Program database (2014-2023). Cases with missing data or complex additional/concurrent procedures were excluded. The primary outcome was a composite of any adverse event (AAE), alongside other subgroupings. Statistics included chi-square or Fisher's exact tests, independent Results: A total of 583 patients underwent primary TEA (mean age = 66.4 ± 13.3; body mass index = 29.9 ± 7.2 kg/m Conclusion: Across this contemporary 10-year national cohort, primary and revision TEAs appeared to show comparable short-term outcomes. These findings cautiously support focused perioperative counseling and suggest that prolonged operative time becomes clinically relevant only at the upper extremes, though incrementally longitudinal, prospective studies are needed for corroboration.